ISI Provides Color on Human Genome Sciences

ISI provided color on Human Genome Sciences HGSI. In a research report published today, ISI stressed some new fey facts about the company. In the report, ISI states, “1. Net pricing of $21k ($32k list price) in Germany (will launch later this week) [we think this price is generally in-line w/ consensus expectation] 2. A little under 10% of US accounts have purchased Benlysta and ~1/3 of hospitals have approved Benlysta on their formulary. 3. 40% of private plans have downloaded the Q-code, 60% will be downloading over the next few weeks. 4. Company believes it's in front of an "inflection point" in Benlysta sales.“ On Thursday, HGSI added 0.56% to its value to finish the day at $23.22. Its shares continued to climb higher in today's pre-market trading, rising 0.78% to $23.40.